Loughborough University
Loughborough, Leicestershire, LE11 3TU, United Kingdom
NCT Number: NCT07267325
Osteoporosis is a systemic bone disorder characterised by a reduced bone mass and structural deterioration, increasing the risk of fragility fractures, particularly in women post-menopause. Bone mass and structure can be assessed by scans.
Antiresorptive medications are commonly prescribed to reduce bone resorption, preventing further bone loss and thus reducing the possibility of fracture. Exercise can also benefit bone mass and structure but current evidence do not show whether exercise is more, or less, effective in combination with antiresorptive medication.
This study will compare the effect of a brief, home-based exercise programme on bone mineral and structural properties in women taking/ not taking antiresorptive medication.
Trial opening soon.
Get Notified55 year–75 year
Female
Interventional
Not applicable
Loughborough, Leicestershire, LE11 3TU, United Kingdom
Exercise can benefit bone density and induce structural changes, leading to a decrease in fracture risk. High-impact exercise is often recommended for promoting bone health as it generates the brief, high strains that stimulate bone adaptation. Brief multidirectional hopping exercises have been demonstrated to be a practical and sustainable intervention with older men, pre- and postmenopausal women. They allow exercise to be conducted on one leg, whilst changes in the other leg can be used as a control to compare what would happen without exercise.
The effects of exercise on bone density and structure may be different in women taking osteoporosis medication, but few studies have examined this group. This study thus aims to evaluate the effects of exercise on bone density and structure according to osteoporosis medication use.
The study will be a 12-month long randomised controlled trial including two groups: with and without antiresorptive osteoporosis medication for at least 12 months. Participants must not plan to change their treatment choices during the 12-month study. All participants will complete a 12-month unilateral hopping exercise intervention.
Screening and baseline measurements will include dual X-ray absorptiometry (DXA) and computed tomography (CT) scans of the hip, blood collection, hop assessment and questionnaires. Eligible participants will then be invited to commence the exercise intervention and randomly allocated an exercise leg, with the contralateral leg being untrained to provide a control leg. Randomisation of exercise and control legs will be performed by selecting an opaque sealed envelopes which contain "R" or "L" letters. It is not possible to blind the participant or researchers supervising the intervention to leg allocation.
An initial familiarisation session will be conducted under supervision. The exercise intervention involves a home-based exercise programme starting at three days per week, with the goal of increasing to seven days per week. It will begin with a warm-up targeting the legs and lower back, followed by a progressive exercise regimen that will gradually increase in technique, intensity, and frequency to ensure safety. It will be personalised according to the participants' physical abilities and responses during or after the exercise. Weekly supervised group sessions will be offered, and used to advise participants on progression of exercise. An exercise logbook will monitor adherence. A questionnaire on any injuries, soreness, or discomfort will be administered monthly online or by phone. Participants will be instructed to reduce intensity and frequency or discontinue exercise if they experience any adverse symptoms or discomfort.
Follow-up measurements will be conducted six and twelve months after the start of the exercise intervention is completed. All measurements , except for the CT scan, will also be repeated after six months with each visit expected to last no more than two hours. whereas at twelve months, all measurements will be repeated. CT scans will take place at Glenfield Hospital, Leicester. All other visits will take place at Loughborough University.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The unilateral high-impact (hopping) exercise will be on one randomly allocated exercise leg, with the contralateral leg being untrained to provide a control leg. Each session will begin with a warm-up targeting the legs and lower back. The progressive exercise regimen consists of multidirectional hopping exercises that will gradually increase in technique, intensity, and frequency to ensure safety. It will be personalised according to the participants' physical abilities and responses during or after the exercise.
Participants in this arm are already taking prescribed antiresorptive medication as part of standard clinical care. The study will not provide or modify the medication.
Time frame: Baseline, 6 months and 12 months
(g) measured by DXA
Time frame: Baseline, 6 months and 12 months
(g/cm^2) measured by DXA
Time frame: Baseline, 6 months and 12 months
(g) measured by DXA
Time frame: Baseline, 6 months and 12 months
(g/cm^2) measured by DXA
Time frame: Baseline, 6 months and 12 months
(g) measured by DXA
Time frame: Baseline, 6 months and 12 months
(g/cm^2) measured by DXA
Time frame: Baseline, 6 months and 12 months
assessed using DXA vertebral morphology
Time frame: Baseline, 6 months and 12 months
weight in Kg
Time frame: Baseline, 6 months and 12 months
Hight in cm
Time frame: Baseline, 6 months and 12 months
will be measured using whole body DXA, reported in Kg
Time frame: Baseline, 6 months and 12 months
will be measured using whole body DXA, reported in Kg
Time frame: Baseline, 6 months and 12 months
(mg/cm^3) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mg/cm^3) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mg/mm) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mg/cm^3) measured by pQCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
mm measured by QCT
Time frame: Baseline, 6 months and 12 months
Bone turnover will be assessed using blood samples to measure C-terminal telopeptide of type I collagen (CTX) which will be reported in µg/L where higher values reflect higher bone turnover, which is associated with increased bone loss
Time frame: Baseline, 6 months and 12 months
measured by force plate reported in Newtons (N)
Time frame: Baseline and 12 months
Total score from the Bone specific Physical Activity Questionnaire will be calculated based on physical activity, intensity and frequency The questionnaire does not have a fixed minimum or maximum score, and values depend on each participant's activity history.
Higher scores indicate higher levels of bone loading physical activity. The contribution of this activity to skeletal adaptation.
Time frame: Baseline, 6 months and 12 months
(mg) Calcium Questionnaire
Time frame: Baseline, 6 months and 12 months
will be assessed using Short Falls Efficacy Scale International (short- FES-I). The scale includes 7 items, each scored from 1 (Not at all concerned) to 4 (Very concerned).
Total scores range from 7 to 28, where higher scores indicate lower confidence and greater fear of falling.
Time frame: Baseline, 6month and 12month
g/cm^2 by DXA
Time frame: Baseline, 6month and 12month
g by DXA
Time frame: Baseline, 6 months and 12 months
(mm^2) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm^4) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm^3) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm^2) measured by pQCT
Time frame: Baseline, 6 months and 12 months
(mm^3) measured by pQCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
g measured by QCT
Time frame: Baseline and 12 months
Buckling ratio measured by QCT
Time frame: Baseline and 12 months
Cross-sectional moment of inertia minimum (cm^4) measured by QCT
Time frame: Baseline and 12 months
Cross-sectional moment of inertia maximum (cm^4) measured by QCT
Time frame: Baseline and 12 months
Cross-sectional moment of area (cm^2) measured by QCT
Contact information is provided by the study sponsor or research team.
Loughborough University
Other
The Effect of Exercise With or Without Antiresorptive Therapy, on Bone Properties in Postmenopausal Women With Low BMD - Randomised Controlled Unilateral Intervention Trial
Acronym: BEAT-OP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06741956
Behavior, Exercise
Seville, Spain
View Trial DetailsNCT06720350
Bone Diseases, Bone Diseases, Metabolic
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06949137
Bone Diseases, Bone Diseases, Metabolic
Nanjing, Jiangsu, China
View Trial DetailsNCT06687889
Back Injuries, Balance, Postural
Samsun, İlkadım, Turkey (Türkiye)
View Trial Details